This tracer exhibited binding affinities comparable to its monomeric counterparts in both in vitro and in vivo models of small (SCLC) and non-small cell lung cancers (NSCLC), suggesting its broad applicability for detecting cancers involving both SSTR2 and integrin αvβ3 [117]. Here, SSTR2 is linked to non-small cell lung carcinoma.